WhitTier Trust Company’s Agios Pharmaceuticals AGIO Stock Holding History

WhitTier Trust Company’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-140	Closed	-$5K	–	966
2020 Q3	$5K	Hold	140	–	–	﹤0.01%	873
2020 Q2	$7K	Hold	140	–	–	﹤0.01%	825
2020 Q1	$5K	Hold	140	–	–	﹤0.01%	852
2019 Q4	$7K	Hold	140	–	–	﹤0.01%	884
2019 Q3	$5K	Hold	140	–	–	﹤0.01%	905
2019 Q2	$7K	Hold	140	–	–	﹤0.01%	868
2019 Q1	$9K	Hold	140	–	–	﹤0.01%	833
2018 Q4	$6K	Hold	140	–	–	﹤0.01%	893
2018 Q3	$11K	Hold	140	–	–	﹤0.01%	807
2018 Q2	$12K	Hold	140	–	–	﹤0.01%	801
2018 Q1	$11K	Hold	140	–	–	﹤0.01%	823
2017 Q4	$8K	Hold	140	–	–	﹤0.01%	816
2017 Q3	$9K	Hold	140	–	–	﹤0.01%	794
2017 Q2	$7K	Buy	+140	New	+$7.16K	﹤0.01%	790

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

WhitTier Trust Company's AGIO Position: Q4 2020 in Review

WhitTier Trust Company sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 140 shares — an estimated $5K sold.

WhitTier Trust Company first reported a position in AGIO in Q2 2017 and held it in 14 quarters. The position peaked at $12K in Q2 2018. 201 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

WhitTier Trust Company reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
WhitTier Trust Company sold 140 Agios Pharmaceuticals shares in Q4 2020, an estimated $5K.
WhitTier Trust Company first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 14 quarters.
WhitTier Trust Company's Agios Pharmaceuticals position peaked at $12K in Q2 2018.
201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on WhitTier Trust Company's 13F filing for Q4 2020, filed 29 Jan 2021.